Devazepide
-
Devazepide
structure -
-
CAS No:
103420-77-5
-
Formula:
C25H20N4O2
-
Chemical Name:
Devazepide
-
Synonyms:
1H-Indole-2-carboxamide,N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-;1H-Indole-2-carboxamide,N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-,(S)-;1H-1,4-Benzodiazepine,1H-indole-2-carboxamide deriv.;N-[(3S)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide;L 364718;MK 329;Devazepide;Devacade;ZINC 01847292
-
CAS No:
Description
ChEBI: An indolecarboxamide obtained by formal condensation of the carboxy group of indole-2-carboxylic acid with the exocyclic amino group of (3S)-3-amino-1-methyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one. A cholecystokinin antagonist used f r treatment of gastrointestinal disorders.
Devazepide is an indolecarboxamide obtained by formal condensation of the carboxy group of indole-2-carboxylic acid with the exocyclic amino group of (3S)-3-amino-1-methyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one. A cholecystokinin antagonist used for treatment of gastrointestinal disorders. It has a role as a cholecystokinin antagonist, a gastrointestinal drug, an antineoplastic agent and an apoptosis inducer. It is a 1,4-benzodiazepinone and an indolecarboxamide.|A derivative of benzodiazepine that acts on the cholecystokinin A (CCKA) receptor to antagonize CCK-8's (SINCALIDE) physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.
Characteristics
77.6
3.62930
white to off-white
1.31±0.1 g/cm3(Predicted)
758.6±60.0 °C(Predicted)
412.6ºC
1.696
DMSO: >5mg/mL
Store at +4°C
6.56E-23mmHg at 25°C
Oral-Mouse LD50: 1 mg/kg; Abdominal cavity-mouse LD50: 1 mg/kg
Flammable; burning produces nitrogen oxides to stimulate smoke
Safety Information
UN 2811 6.1 / PGI
3
28
28-36/37-45
NL5994460
T+
Storehouse ventilated at low temperature and dry; stored separately from oxidants, alkalis, food additives
P264-P301 + P310
H300
|Danger|H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]|P264, P270, P301+P310, P321, P330, P405, and P501|Aggregated GHS information provided by 127 companies from 1 notifications to the ECHA C&L Inventory.
Drug Information
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)
Devazepide
Computed Properties
Molecular Weight:408.5
XLogP3:4.2
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:408.15862589
Monoisotopic Mass:408.15862589
Topological Polar Surface Area:77.6
Heavy Atom Count:31
Complexity:716
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes